Today: 22 May 2026
Browse Category

NASDAQ:GPX 7 January 2026

Structure Therapeutics stock climbs on $100 million Roche-Genentech patent deal; what investors watch next

Structure Therapeutics stock climbs on $100 million Roche-Genentech patent deal; what investors watch next

Structure Therapeutics shares rose 5.6% to $66.75 after an SEC filing revealed a $100 million upfront payment and low single-digit royalties from Roche and Genentech for a patent license covering oral GLP-1 drugs, including CT-996. The agreement does not affect Structure’s lead candidate, aleniglipron. Full contract details will be disclosed in the annual report.
7 January 2026
·

Stock Market Today

  • FTSE 100 Edges Higher as AstraZeneca Gains Oncology Drug Approvals
    May 22, 2026, 12:20 PM EDT. London's FTSE 100 closed the week up 0.22% amid mixed economic data. UK retail sales dropped 1.3% in April, missing expectations, reflecting early impact from the Middle East conflict on consumer spending. UK borrowing also exceeded forecasts, reaching 24.3 billion pounds. Consumer confidence improved slightly, rising two points to -23 in May according to GfK, but uncertainty remains over inflation and interest rates. On the corporate front, AstraZeneca shares dipped 0.64% after receiving European Union recommendations for approval of its oncology drugs camizestrant and Enhertu, while its partner Daiichi Sankyo's Datroway won FDA approval for treating metastatic breast cancer. These developments mark progression in AstraZeneca's cancer therapy portfolio amid cautious market sentiment.

Latest articles

Navitas Stock Up Again as Market Looks at AI Power Trade

Navitas Stock Up Again as Market Looks at AI Power Trade

22 May 2026
Navitas Semiconductor shares jumped 16.33% to $28.36 on Friday, following an 18.32% surge Wednesday ahead of its PCIM 2026 showcase. The company reported Q1 revenue of $8.6 million, up 18% from the prior quarter but down from $14 million a year ago. Navitas plans to demonstrate new high-efficiency power boards for AI data centers. Analysts say breakeven may require quarterly sales above $30 million.
Qualcomm Shares Surge 13% After Stellantis Deal Announced

Qualcomm Shares Surge 13% After Stellantis Deal Announced

22 May 2026
Qualcomm shares jumped 12.7% to $240.44 after Stellantis expanded a multi-year deal to use Snapdragon chips in cockpit, connectivity, and driver-assistance systems. The agreement includes the Ride Pilot platform for Level 2+ hands-free driving. Analysts remain divided, with price targets ranging from $150 to $300 and a broad Hold consensus. Qualcomm reported record automotive chip revenue and 20% growth in automotive and IoT segments.
Dutch Regulator Targets Gas Bill Fine Print, Consumers Caught Off Guard

Dutch Regulator Targets Gas Bill Fine Print, Consumers Caught Off Guard

22 May 2026
Dutch regulator ACM has barred energy suppliers from raising prices mid-term on fixed gas contracts to cover future green-gas and EU carbon costs. Budget Thuis, Delta Energie, Innova Energie, Mega, and Vattenfall had clauses allowing such increases, with potential annual extras up to €326 for some households. The EU’s ETS2 carbon market and Dutch green-gas rules take effect from 2027 and 2028.
Go toTop